3929 POINT EDEN WAY, HAYWARD, CA
Board Appointment - Ma. Fatima D. Francisco Joins Eikon Therapeutics Board
Investor Presentation
Reports First Quarter 2026 Financial Results and Provides Clinical Updates
Financial Results, Press Release
Amendment and Restatement of Certificate of Incorporation and Bylaws
Q1
FY 2025
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(4)
Certificate
Effectiveness Notice
Amended Registration Statement for Securities
Registration of Securities
S-1
Notice of Exempt Offering of Securities
No filings found
Initial Statement of Beneficial Ownership
Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
S-1MEF